Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Business & Industry
- Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
- Amgen and the Amgen Foundation commit up to $12.5 million to support COVID-19 relief efforts
- Roche response to COVID-19 pandemic
- AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19
- Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
Research & Development
- Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19
- CAR macrophages go beyond T cells to fight solid tumors
- Vivli to launch a portal for sharing data from COVID-19 trials
- Understanding how COVID-19 affects children vital to slowing pandemic
- Favipiravir flu drug 'clearly effective' in treating COVID-19
- COVID-19: The immune system can fight back
- New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus
Conferences & Events
- The COVID-19 coronavirus epidemic has a natural origin
- Pre-Filled Syringes West Coast 2020
- Pre-Filled Syringes East Coast Conference 2020
- SMi's 4th Annual Pharmaceutical Microbiology West Coast
- SMi's 20th Annual Pain Therapeutics Conference 2020
- SMi's 3rd Annual Pharmaceutical Microbiology East Coast
- SMi's 22nd Annual Superbugs & Superdrugs Conference 2020
Regulatory Affairs
- The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients
- FDA continues to facilitate development of COVID-19 treatments
- FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19
- FDA approves new treatment for adults with Cushing's disease
- FDA approves first generic of Daraprim